The Children’s Hospital Los Angeles (CHLA) has announced that it will shut down the Transyouth Health and Development program by the end of July.
The move comes amid mounting federal pressure to stop mutilating and sterilizing children in the name of “gender science.”
There have been reports that CHLA is under investigation by the Department of Health and Human Services (HHS) for potential violations of new federal guidelines issued by the Trump administration regarding sex changes for minors.
The hospital is one of the few in the nation that will provide sex change surgeries and hormones to kids under 18 who receive taxpayer-funded healthcare.
“Federal agencies, including the Department of Justice, Health and Human Services, and the Centers for Medicare and Medicaid Services, have made it clear there will be consequences, potentially civil and criminal, for entities pushing irreversible procedures on vulnerable minors,” the hospital wrote to staff.
“The threats are no longer theoretical,” the hospital asserted.
“CHLA has a responsibility to navigate this complex and uncertain regulatory environment in a way that allows us to remain open as much as possible for as many as possible,” the email continued. “This painful and difficult decision was driven by the need to safeguard CHLA’s ability to operate amid significant external pressures beyond our control.”
The Post Millennial reports, “CHLA is more dependent on public funding than any other pediatric center in California, making it especially vulnerable to changes in federal policy. Around 40 percent of all pediatric beds in Los Angeles are housed at CHLA, and executives say preserving access to care for the largest number of children, particularly low-income and chronically ill kids, must come first.”
In April, HHS established a dedicated tip line for whistleblowers to report cases of chemical and surgical sex change procedures performed on minors.
To enforce Trump’s executive order “Protecting Children From Chemical and Surgical Mutilation,” the new tip line allows individuals to report concerns related to the administration of puberty blockers, cross-sex hormones, and sex change surgeries on children.
